Skip to content
effecthub

Consensus vs OpenEvidence

Two fact sheets from our own research, side by side — pricing, platforms, API access and status re-checked by us rather than quoted from the vendors.

The short answer

Free plan
Both — Consensus has a free plan, OpenEvidence is free to use
Higher Trust score
OpenEvidence — 91 vs 81 for Consensus
Best fit
Consensus: Checking whether a specific claim has support across published studies · OpenEvidence: US physicians, NPs and PAs who want cited point-of-care answers instead of a general chatbot
Status
We could not check OpenEvidence — its site turns automated checks away; Consensus was up on Sep 6, 2026

From our own records as of each tool's last check. Anything we have not confirmed is left out rather than guessed. How we verify

Side by side

FactConsensusOpenEvidence
CategoryAcademic Search & Literature ReviewHealthcare & Medical
Pricing modelFreemiumFree
Trust score81 / 10091 / 100
PlatformsWeb, iOS, AndroidWeb, iOS, Android
CompanyConsensusOpenEvidence Inc.
Launched2021—
Last verifiedSep 6, 2026Sep 6, 2026

What our research says

Consensus

Useful when you want to know what a body of literature actually concludes rather than reading one paper at a time, but it orients you, it does not replace reading them.

Pros

  • Every answer is tied to specific papers with study design and sample size
  • Free tier is a standing plan rather than a time-limited trial
  • The yes-or-no consensus meter is a fast orientation device
  • Covers a very large index of peer-reviewed literature

Cons

  • Summaries can flatten real disagreement between studies into false consensus
  • Coverage skews to indexed English-language biomedical work
  • Pricing cannot be verified from outside; the site blocks automated access
  • Free allowance of the deeper analyses runs out quickly in real use

OpenEvidence

For a US clinician this is the obvious free alternative to a general chatbot: the answers cite the journals you would cite yourself, the licensed NEJM and JAMA text is something ChatGPT cannot legally see, and it costs nothing. The trade is that the business model is pharmaceutical advertising inside a clinical tool, and the service is closed to everyone without a US professional identifier.

Pros

  • Every claim carries a citation, with licensed full text from NEJM, JAMA, Nature and Cochrane rather than abstracts
  • Free with no paid tier, and CME credit accrues from ordinary use
  • Evidence grading shows how strong the support for an answer is
  • Mobile apps add ambient documentation and voice mode for use during consultations

Cons

  • Revenue is pharmaceutical advertising placed next to clinical answers, a conflict worth keeping in view
  • US-only verification shuts out clinicians elsewhere, and the guideline corpus leans US practice
  • The site refuses automated access and the vendor publishes little about accuracy on complex cases
  • No API or integration path for health systems that want it inside the EHR

Which one fits

Choose Consensus if you need

  • Checking whether a specific claim has support across published studies
  • Clinicians and students orienting quickly in an unfamiliar literature
  • Anyone who wants citations attached to every summarised claim

Choose OpenEvidence if you need

  • US physicians, NPs and PAs who want cited point-of-care answers instead of a general chatbot
  • Residents and trainees who want CME credit and evidence grading built into the lookup
  • Clinicians who need the licensed full text of NEJM and JAMA articles in the answer

Consensus vs OpenEvidence: the questions people ask

Does Consensus or OpenEvidence have a free tier?

Both: Consensus has a free tier, and OpenEvidence is free to use.

All Consensus alternatives →Browse all Academic Search & Literature Review →